MICHAEL VOLK to Waiting Lists
This is a "connection" page, showing publications MICHAEL VOLK has written about Waiting Lists.
Connection Strength
2.342
-
Center differences in model for end-stage liver disease exceptions: fairness, local culture, and norms of practice. Liver Transpl. 2013 Dec; 19(12):1287-8.
Score: 0.365
-
Decision making in liver transplant selection committees: a multicenter study. Ann Intern Med. 2011 Oct 18; 155(8):503-8.
Score: 0.318
-
Quality measures in pre-liver transplant care by the Practice Metrics Committee of the American Association for the Study of Liver Diseases. Hepatology. 2024 09 01; 80(3):742-753.
Score: 0.188
-
Association of Frailty and Sex With Wait List Mortality in Liver Transplant Candidates in the Multicenter Functional Assessment in Liver Transplantation (FrAILT) Study. JAMA Surg. 2021 03 01; 156(3):256-262.
Score: 0.152
-
Identifying an Optimal Liver Frailty Index Cutoff to Predict Waitlist Mortality in Liver Transplant Candidates. Hepatology. 2021 03; 73(3):1132-1139.
Score: 0.149
-
Frailty Associated With Waitlist Mortality Independent of Ascites and Hepatic Encephalopathy in a Multicenter Study. Gastroenterology. 2019 05; 156(6):1675-1682.
Score: 0.132
-
Factors Associated with Survival of Patients With Severe Acute-On-Chronic Liver Failure Before and After Liver?Transplantation. Gastroenterology. 2019 Apr; 156(5):1381-1391.e3.
Score: 0.131
-
Analysis of Liver Offers to Pediatric Candidates on the Transplant Wait List. Gastroenterology. 2017 10; 153(4):988-995.
Score: 0.118
-
Maximizing the benefit of liver transplantation: Implications for organ allocation and clinical practice. Transplant Rev (Orlando). 2016 Jan; 30(1):1-2.
Score: 0.106
-
A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list. J Hepatol. 2014 Feb; 60(2):290-7.
Score: 0.091
-
Patient decision making about organ quality in liver transplantation. Liver Transpl. 2011 Dec; 17(12):1387-93.
Score: 0.080
-
Variation in organ quality between liver transplant centers. Am J Transplant. 2011 May; 11(5):958-64.
Score: 0.077
-
Estimation of the harm to the waiting list as a crucial factor in the selection of patients with hepatocellular carcinoma for liver transplantation. Transplant Proc. 2010 May; 42(4):1194-6.
Score: 0.072
-
Geographic variation in organ availability is responsible for disparities in liver transplantation between Hispanics and Caucasians. Am J Transplant. 2009 Sep; 9(9):2113-8.
Score: 0.068
-
Impact of the model for end-stage liver disease allocation policy on the use of high-risk organs for liver transplantation. Gastroenterology. 2008 Nov; 135(5):1568-74.
Score: 0.065
-
Beyond utilitarianism: a method for analyzing competing ethical principles in a decision analysis of liver transplantation. Med Decis Making. 2008 Sep-Oct; 28(5):763-72.
Score: 0.064
-
A novel model measuring the harm of transplanting hepatocellular carcinoma exceeding Milan criteria. Am J Transplant. 2008 Apr; 8(4):839-46.
Score: 0.062
-
Liver transplantation provides survival benefit at all levels of frailty: From the Multicenter Functional Assessment in Liver Transplantation Study. Hepatology. 2025 Apr 01; 81(4):1269-1275.
Score: 0.048
-
A 2020 update on liver transplant for hepatocellular carcinoma. Expert Rev Gastroenterol Hepatol. 2020 Oct; 14(10):885-900.
Score: 0.037
-
Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: a cost-benefit analysis while awaiting data on sorafenib safety. Hepatology. 2010 Jan; 51(1):165-73.
Score: 0.018